Medical Supply International USA, Inc. (MSIU) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 0.05 means the share price is 0.05 times one year of earnings per share.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMedical Supply International USA, Inc. (MSIU) trades at $0.0008. Medical Supply International USA, Inc. operates in the healthcare industry in China, providing rehabilitation and specialized hospital services. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for MSIU: MSIU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Medical Supply International USA, Inc. (MSIU) Healthcare & Pipeline Overview
Medical Supply International USA, Inc. provides rehabilitation and specialized hospital services in China, focusing on rehabilitative care, maternity services, and specialized treatments. Operating a rehabilitative center and specialized hospital, the company leverages advanced medical technologies like 4-D ultrasound and IPL systems, distinguishing itself in the Chinese healthcare market.
What Is the Investment Thesis for MSIU?
Medical Supply International USA, Inc. presents a focused investment opportunity within the Chinese healthcare sector, specifically in rehabilitation and specialized hospital services. With a P/E ratio of 0.05 and a profit margin of 14.0%, the company demonstrates potential profitability. Key value drivers include the increasing demand for rehabilitation services in China and the company's specialized medical technologies. Growth catalysts include expanding its service offerings and geographic reach within China. Investors should carefully consider these factors alongside the company's financial performance and market position.
Based on FMP financials and quantitative analysis
MSIU Key Highlights
Profit Margin of 14.0% indicates potential profitability in the specialized healthcare services.
- Gross Margin of 62.4% suggests efficient cost management in service delivery.
- P/E Ratio of 0.05 indicates the stock may be undervalued relative to its earnings.
- The company's focus on rehabilitation services addresses a growing demand in the Chinese healthcare market.
- Operation of specialized hospitals and outpatient clinics provides diversified revenue streams.
Who Are MSIU's Competitors?
MSIU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BJDX Bluejay Diagnostics, Inc. | $0.84 | -1.12% | 30 5-pillar | |
| NVNO enVVeno Medical Corporation | $8.10 | +0.75% | $5.63M | 33 5-pillar |
| BDMD Baird Medical Investment Holdings Limited | $0.75 | +0.91% | $31.7M | — |
| SNWV SANUWAVE Health, Inc. | $4.82 | +4.33% | $41.5M | 36 5-pillar |
| SRTS Sensus Healthcare, Inc. | $2.98 | +1.02% | $49.1M | 31 5-pillar |
| HYPD Hyperion DeFi, Inc. | $3.73 | +1.91% | $56.5M | 36 5-pillar |
| LNSR LENSAR, Inc. | $6.75 | +2.74% | $82.9M | 45 5-pillar |
| APYX Apyx Medical Corporation | $2.55 | +2.00% | $107M | 33 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MSIU's Key Strengths?
Specialized focus on rehabilitation and maternity services.
- Use of advanced medical technologies.
- Established presence in the Chinese healthcare market.
- Integrated service offerings from rehabilitation to specialized treatments.
What Are MSIU's Weaknesses?
High beta indicating significant stock price volatility.
- OTC market listing introduces additional risks.
- Limited geographic diversification within China.
- Dependence on the Chinese healthcare market.
What Are the Key Risks for MSIU?
Regulatory changes in the Chinese healthcare market impacting operations.
- Competition from domestic and international healthcare providers.
- Economic fluctuations in China affecting healthcare spending.
- Medical malpractice claims and liabilities.
- High beta indicating significant stock price volatility.
What Are MSIU's Competitive Advantages?
- Specialized Focus: Focus on rehabilitation and specialized services creates a niche market position.
- Advanced Technology: Use of advanced medical technologies like 4-D ultrasound and IPL systems.
- Established Presence: Long-standing presence in the Chinese healthcare market since 2001.
- Integrated Services: Offering a range of services from rehabilitation to maternity care.
What Does MSIU Do?
Medical Supply International USA, Inc., established in 2001 and headquartered in Wan Chai, Hong Kong, operates within the healthcare industry in the People's Republic of China. The company focuses on providing rehabilitation services and specialized hospital services through its subsidiaries. Its core operations include a rehabilitative center catering to patients recovering from serious injuries, illnesses, or addictions, offering therapeutic and medical treatments. Additionally, the company runs a maternity and specialized service hospital, providing comprehensive care for mothers and newborns. MSIU also operates an outpatient clinic, offering private outpatient services and health check-up services. The company provides obstetrics and gynecology services. It utilizes advanced medical technologies, including 4-D ultrasound systems for medical scanning and IPL systems for treating various skin disorders and cosmetic surgery. Formerly known as Master Spirit International USA Inc., the company rebranded to Medical Supply International USA, Inc. in October 2018, marking a strategic shift in its business focus and market positioning. The company's services are primarily concentrated within China, addressing the growing demand for specialized healthcare services and rehabilitation care.
What Products and Services Does MSIU Offer?
- Operates rehabilitative centers for patients recovering from injuries, illnesses, or addictions.
- Provides maternity and specialized hospital services.
- Offers therapeutic and medical treatments.
- Runs outpatient clinics providing private consultations and health check-ups.
- Offers obstetrics and gynecology services.
- Utilizes 4-D ultrasound systems for medical scanning.
- Applies IPL systems for treating skin disorders and cosmetic surgery.
How Does MSIU Make Money?
- Generates revenue through rehabilitation services provided at its centers.
- Earns income from maternity and specialized hospital services.
- Collects fees for outpatient clinic services and health check-ups.
- Derives revenue from specialized medical treatments and procedures.
What Industry Does MSIU Operate In?
Medical Supply International USA, Inc. operates in the growing Chinese healthcare market, which is driven by an aging population and increasing healthcare spending. The demand for rehabilitation services and specialized medical treatments is on the rise. The competitive landscape includes both domestic and international healthcare providers. MSIU differentiates itself through its focus on rehabilitation and specialized services, leveraging advanced medical technologies. The Chinese healthcare market is subject to regulatory changes and evolving healthcare policies, which can impact the company's operations and growth prospects.
Who Are MSIU's Key Customers?
- Patients recovering from serious injuries, illnesses, or addictions.
- Expectant mothers seeking maternity care services.
- Individuals seeking specialized medical treatments and procedures.
- Private outpatients seeking consultations and health check-ups.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Medical Supply International USA, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Hong Kong, HK. The company is led by CEO Christopher Ginas. MSIU has traded publicly since 2009.
Key Financial Metrics
Return on assets is -31.6%, showing how much profit it generates from its asset base. A current ratio of 0.13 means current liabilities exceed short-term assets, a liquidity point worth watching.
MSIU Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
MSIU Latest News
No recent news available for MSIU.
MSIU Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MSIU.
Price Targets
Wall Street price target analysis for MSIU.
MSIU MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MSIU; grades run from A+ (80-100) to F (below 30).
Leadership: Christopher Ginas
CEO
Christopher Ginas serves as the Chief Executive Officer of Medical Supply International USA, Inc. His background includes experience in healthcare management and strategic leadership. He has been involved in overseeing the company's operations and strategic direction, focusing on expanding its presence in the Chinese healthcare market. His expertise lies in healthcare administration and business development, with a focus on rehabilitation and specialized hospital services.
Track Record: Under Christopher Ginas's leadership, Medical Supply International USA, Inc. has focused on expanding its rehabilitation services and adopting advanced medical technologies. Key milestones include the rebranding of the company in 2018 and the continued operation of its rehabilitative center and specialized hospital. His strategic decisions have aimed at enhancing the company's market position and service offerings within the Chinese healthcare sector.
MSIU OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Medical Supply International USA, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, increasing the risk for investors compared to companies listed on major exchanges like NYSE or NASDAQ. The lack of stringent listing requirements can lead to greater information asymmetry and potential for fraudulent activities.
- OTC Tier: OTC Other
- Limited Disclosure: Lack of regular financial reporting increases information asymmetry.
- Low Liquidity: Low trading volumes and wide bid-ask spreads can lead to price volatility.
- Shell Risk: The detected shell risk indicates a potential for fraudulent activities or lack of legitimate business operations.
- Regulatory Scrutiny: OTC-listed companies are subject to less regulatory oversight compared to those on major exchanges.
- Delisting Risk: Failure to meet minimum listing requirements can result in delisting from the OTC market.
- Verify the company's business operations and revenue sources.
- Review the company's financial statements, if available.
- Assess the company's management team and their track record.
- Check for any regulatory actions or legal disputes involving the company.
- Evaluate the company's market position and competitive landscape.
- Investigate the reasons for the company's OTC listing and shell risk.
- Consult with a financial advisor before investing.
- Operational rehabilitative center and specialized hospital.
- Focus on rehabilitation and maternity services.
- Use of advanced medical technologies.
- Established presence in the Chinese healthcare market.
MSIU Healthcare Stock FAQ
What are the main risks for MSIU?
The main risks for Medical Supply International USA, Inc. include regulatory changes in the Chinese healthcare market, which could impact its operations and profitability. Competition from domestic and international healthcare providers poses a threat to its market share. Economic fluctuations in China could affect healthcare spending and demand for its services.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- OTC market data may be less reliable than major exchange data.
- Financial data is limited and may not be fully comprehensive.